Torthaí cuardaigh - Tianzeng Chen
- 1 - 2 toradh as 2 á dtaispeáint
-
1
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy de réir Maria Moscvin, Christine‐Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter G. Czarnecki, Filippo Bagnoli, Niccolò Bolli, Paul G. Richardson, Helmut G. Rennke, Meletios Α. Dimopoulos, Efstathios Kastritis, Giada Bianchi
Foilsithe / Cruthaithe 2023Artigo -
2
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling de réir Matthew Ho, Tianzeng Chen, Jiye Liu, Paul Dowling, Teru Hideshima, Li Zhang, Eugenio Morelli, Gulden Camci‐Unal, Xinchen Wu, Yu‐Tzu Tai, Kenneth Wen, Mehmet Samur, Robert Schlossman, Ralph Mazitschek, Emma Kavanagh, Sinéad Lindsay, Takeshi Harada, Amanda McCann, Kenneth C. Anderson, Peter O’Gorman, Giada Bianchi
Foilsithe / Cruthaithe 2019Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Immunology
Alternative complement pathway
Antibody
Atypical hemolytic uremic syndrome
Biochemistry
Biology
Bone marrow
Bortezomib
Cancer research
Carfilzomib
Cell biology
Chemistry
Complement system
Disease
Environmental health
Gene
HDAC3
Histone
Histone deacetylase
Internal medicine
Medicine
Microvesicles
Multiple myeloma
Population
Stromal cell
Thrombotic microangiopathy
microRNA